Circumventing Antivector Immunity: Potential Use of Nonhuman Adenoviral Vectors-Reference-Cited by-同舟云学术

Circumventing Antivector Immunity: Potential Use of Nonhuman Adenoviral Vectors

Published:2014-04 Issue:4 Volume:25 Page:285-300
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Lopez-Gordo Estrella¹,Podgorski Iva I.²,Downes Nicholas³,Alemany Ramon⁴

Affiliation:

1. Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, United Kingdom.

2. Institute for Veterinary Medical Research, Centre for Agricultural Research, Hungarian Academy of Sciences, Budapest 1143, Hungary.

3. A.I. Virtanen Institute, Department of Biotechnology and Molecular Medicine, University of Eastern Finland, Kuopio 70211, Finland.

4. Laboratori de Recerca Translacional, Institut Català d'Oncologia, El Instituto de Investigación Biomédica de Bellvitge, Barcelona 08907, Spain.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2013.228

Reference225 articles.

1. Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

2. Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5

3. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

4. Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors

5. Adenovirus receptors: implications for targeting of viral vectors

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets;International Journal of Molecular Sciences;2024-07-04

2. Exploring the Potential and Challenges of CRISPR Delivery and Therapeutics for Genetic Disease Treatment;Advanced Functional Materials;2024-05-27

3. Next-generation biological vector platforms for in vivo delivery of genome editing agents;Current Opinion in Biotechnology;2024-02

4. Optoelectronic control of cardiac rhythm: Toward shock‐free ambulatory cardioversion of atrial fibrillation;Journal of Internal Medicine;2023-11-14

5. Novel hybrid silicon-lipid nanoparticles deliver a siRNA to cure autosomal dominant osteopetrosis in mice. Implications for gene therapy in humans;Molecular Therapy - Nucleic Acids;2023-09